AN2 Therapeutics Stock (NASDAQ: ANTX) stock price, news, charts, stock research, profile.
Open | $2.390 |
Close | $2.280 |
Volume / Avg. | 178.962K / 466.865K |
Day Range | 2.280 - 2.400 |
52 Wk Range | 2.310 - 22.220 |
Market Cap | $68.174M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 25 |
Short Interest | 1.32% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of AN2 Therapeutics (NASDAQ: ANTX) through any online brokerage.
Other companies in AN2 Therapeutics’s space includes: SCYNEXIS (NASDAQ:SCYX), CalciMedica (NASDAQ:CALC), Jaguar Health (NASDAQ:JAGX), Ocuphire Pharma (NASDAQ:OCUP) and Marinus Pharma (NASDAQ:MRNS).
The latest price target for AN2 Therapeutics (NASDAQ: ANTX) was reported by JMP Securities on Tuesday, April 2, 2024. The analyst firm set a price target for 6.00 expecting ANTX to rise to within 12 months (a possible 162.01% upside). 7 analyst firms have reported ratings in the last year.
The stock price for AN2 Therapeutics (NASDAQ: ANTX) is $2.29 last updated April 25, 2024 at 5:21 PM EDT.
A quarterly cash dividend of $0.66 per share of Class A Common Stock. The quarterly cash dividend was payable on February 1, 2018 to stockholders of record on January 11, 2018.
AN2 Therapeutics’s Q1 earnings are confirmed for Thursday, May 9, 2024.
There is no upcoming split for AN2 Therapeutics.
AN2 Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.